So far, the FTC has not taken an action against a pharmacy benefit manager

In a 71-page report, the Federal Trade Commission criticized pharmacy benefit managers, accusing them of hiking drug prices. “These powerful middlemen may be profiting by inflating drug costs and squeezing Main Street pharmacies,” the report said.

So far, the regulator has not taken action against a benefit manager—companies that function as middlemen between drugmakers and consumers. But the industry fears the report suggests a lawsuit or a formal investigation may be in the works.

Meanwhile
Federal regulators banned NGL, a digital platform, from serving minors, accusing the app of deceptive practices by exaggerating its use of AI to curb cyberbullying. The FTC fined the app and its founders $5 million. It is the first time it ordered a digital platform to stop serving those below 18.